Drug Approvals

FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis

FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis

30 Jun 2025

1 min read

FDA Approves Dupixent for Bullous Pemphigoid

FDA Approves Dupixent for Bullous Pemphigoid

24 Jun 2025

1 min read

FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma

FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma

23 Jun 2025

2 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com